ALAMEDA, Calif.--(BUSINESS WIRE)--Arriva Pharmaceuticals, a biopharmaceutical company focused on developing anti-inflammatory therapies, announced today the formation of the company’s scientific advisory board. The seven advisory board members, who are acknowledged as key thought leaders in the field of respiratory disease, will play an important role in the development of Arriva’s clinical programs.
